The reality of pharmacogenomics: optimizing therapeutic decision making.
作者信息
Lee Craig R, Zeldin Darryl C
出版信息
Environ Health Perspect. 2003 Aug;111(11):A566-7. doi: 10.1289/ehp.111-a566.
Abstract
摘要
相似文献
1
The reality of pharmacogenomics: optimizing therapeutic decision making.药物基因组学的现实：优化治疗决策
Environ Health Perspect. 2003 Aug;111(11):A566-7. doi: 10.1289/ehp.111-a566.
2
Pharmacogenomics: the promise of personalized medicine.药物基因组学：个性化医疗的前景。
Environ Health Perspect. 2003 Aug;111(11):A581-9. doi: 10.1289/ehp.111-1241640.
3
Murine pharmacogenomics: using the mouse to understand the genetics of drug therapy.小鼠药物基因组学：利用小鼠了解药物治疗的遗传学
Pharmacogenomics. 2002 Nov;3(6):781-90. doi: 10.1517/14622416.3.6.781.
4
[Pharmacogenomics genomics approaches to optimizing drug therapy].[药物基因组学：优化药物治疗的基因组学方法]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Apr;19(2):156-8.
5
Pharmacogenetics and pharmacogenomics in the discovery and development of medicines.药物遗传学与药物基因组学在药物发现与开发中的应用
Novartis Found Symp. 2000;229:63-6; discussion 66-70. doi: 10.1002/047084664x.ch9.
6
Pharmacogenomics and personalized medicine--a global reality check.药物基因组学与个性化医疗——全球现状审视
Clin Chem Lab Med. 2007;45(7):799-800. doi: 10.1515/CCLM.2007.180.
7
Challenges and opportunities in pharmacogenomics and therapeutics.药物基因组学与治疗学中的挑战与机遇。
J Manag Care Pharm. 2007 Sep;13(7):607-8. doi: 10.18553/jmcp.2007.13.7.607.
8
SNPs and pharmacogenomics.单核苷酸多态性与药物基因组学
Pharmacogenomics. 2002 Sep;3(5):583-6. doi: 10.1517/14622416.3.5.583.
9
SNP databases and pharmacogenetics: great start, but a long way to go.单核苷酸多态性数据库与药物遗传学：良好开端，但任重道远。
Hum Mutat. 2002 Sep;20(3):174-9. doi: 10.1002/humu.10115.
10
Pharmacogenetic screening for drug therapy: from single gene markers to decision making in the next generation sequencing era.药物治疗的遗传药理学筛查：从单基因标记到下一代测序时代的决策。
Pathology. 2012 Feb;44(2):166-80. doi: 10.1097/PAT.0b013e32834f4d69.
本文引用的文献
1
Pharmacogenomics--drug disposition, drug targets, and side effects.药物基因组学——药物处置、药物靶点及副作用。
N Engl J Med. 2003 Feb 6;348(6):538-49. doi: 10.1056/NEJMra020526.
2
Pharmacogenetics and the practice of medicine.药物遗传学与医学实践
Nature. 2000 Jun 15;405(6788):857-65. doi: 10.1038/35015728.
3
Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.β2-肾上腺素能受体基因多态性对沙丁胺醇支气管扩张药效学的影响。
Clin Pharmacol Ther. 1999 May;65(5):519-25. doi: 10.1016/S0009-9236(99)70071-8.
4
Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer.奥美拉唑代谢的基因差异对幽门螺杆菌感染及消化性溃疡治愈率的影响。
Ann Intern Med. 1998 Dec 15;129(12):1027-30. doi: 10.7326/0003-4819-129-12-199812150-00006.
5
Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms.硫嘌呤 S - 甲基转移酶的基因多态性：临床重要性及分子机制
Pharmacogenetics. 1996 Aug;6(4):279-90. doi: 10.1097/00008571-199608000-00001.
Zotero 插件